Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
XYLANASE MUTANT AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/054244
Kind Code:
A1
Abstract:
A xylanase mutant and application thereof. The amino acid sequence of the xylanase mutant is as shown in SEQ ID No:1; and the xylanase mutant is obtained by coding amino acids in fungal Neocallimastigomycota xylanase amino acid sequence SEQ ID No:3 to cause the following changes N207S,G208S,A210S. The mutant can well act in gastrointestinal environment of livestock and poultry and has a relatively ideal heat resistant property; therefore, the mutant is particular suitable for being used as a feed additive.

Inventors:
HUANG ZUNXI (CN)
MIAO HUABIAO (CN)
HAN NANYU (CN)
Application Number:
PCT/CN2017/101394
Publication Date:
March 29, 2018
Filing Date:
September 12, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV YUNNAN (CN)
International Classes:
C12N9/24; A23K20/00; A23K20/189; C12N1/00; C12N1/19; C12N9/00; C12N15/00; C12N15/56; C12N15/81
Foreign References:
CN106282141A2017-01-04
CN104109660A2014-10-22
CN102757947A2012-10-31
CN101392266A2009-03-25
Other References:
HAN, N.Y. ET AL.: "Improving the thermostability of a fungal GH11 xylanase via site-directed mutagenesis guided by sequence and structural analysis", BIOTECHNOL BIOFUELS., vol. 10, no. 133, 23 May 2017 (2017-05-23), pages 1 - 12, XP055603187, DOI: 10.1186/s13068-017-0824-y
DATABASE Nucleotide 12 March 2015 (2015-03-12), "PREDOCTED: Homo sapiens receptor-interacting serine-threonine kinase 2 (RIPK2), transcript variant X2, mRNA", XP055603193, retrieved from NCBI Database accession no. XM_011517357. 1
DATABASE Nucleotide 12 March 2015 (2015-03-12), "PREDOCTED: Homo sapiens receptor-interacting serine-threonine kinase 2 (RIPK2), transcript variant XI, mRNA", XP055603194, retrieved from NCBI Database accession no. XM_005251092. 2
Attorney, Agent or Firm:
BEIJING ZHCC INTELLECTUAL PROPERTY CO., LTD. (CN)
Download PDF: